Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Screening Europe

Neil Carragher's Biography

Neil Carragher, Principal Investigator, University of Edinburgh

Neil Carragher graduated from the University of Aberdeen, Scotland UK in 1992 prior to accepting a position at the Yamanouchi Research Institute, Oxford, England UK where he gained his PhD. He held consecutive postdoctoral positions within the Department of Pathology, University of Washington, Seattle, USA and at the Beatson Institute for Cancer Research, Glasgow, Scotland UK. In 2004 Neil returned to the pharmaceutical industry as Principal Scientist with the Advanced Science and Technology Laboratory at AstraZeneca where he pioneered early multiparametric high-content phenotypic screening approaches. In 2010 he took up the post of Principal Investigator of Drug Discovery at the University of Edinburgh where he leads a research group and is currently co-director of the Edinburgh Cancer Discovery Unit. Current research interests include advancing High-content analysis, phenotypic screening, Reverse Phase Protein Array technology and cancer drug discovery.

Neil Carragher Image

Advancing Phenotypic Screening Strategies Using Combined Imaging and Pathway Profiling Approaches

Tuesday, 17 February 2015 at 09:00

Add to Calendar ▼2015-02-17 09:00:002015-02-17 10:00:00Europe/LondonAdvancing Phenotypic Screening Strategies Using Combined Imaging and Pathway Profiling ApproachesScreening Europe in Berlin, GermanyBerlin,

We demonstrate how high content imaging and Reverse Phase Protein Microarray (RPPA) technologies can combine to enable a robust and unbiased phenotypic drug discovery strategy. We will provide case studies demonstrating how we have applied these technologies to advanced models of cancer to progress new chemical entities and novel drug combinations towards late stage preclinical development.

Add to Calendar ▼2015-02-17 00:00:002015-02-18 00:00:00Europe/LondonScreening EuropeScreening Europe in Berlin, GermanyBerlin,